Virtua Health Adds Evolv Technology As Its Weapons Detection Partner

Evolv Technology (NASDAQ: EVLV) has partnered with Virtua Health, New Jersey's largest healthcare provider, to enhance safety with AI-based weapons detection.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

05/21/2024 - 08:00 AM

South New Jersey’s Largest Healthcare Provider Incorporates AI Tech as Part of Multifaceted Campaign Against Gun Violence

WALTHAM, Mass.--(BUSINESS WIRE)-- Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with Virtua Health, a not-for-profit health system in New Jersey.

Virtua Health will use 14 Evolv Express® systems at five of its hospitals and two of its health-and-wellness campuses. So far, the weapons detection technology has been installed at five facilities. Evolv Express uses sensor technology combined with AI to tell the difference between many everyday metal items people carry in their pockets and certain objects that pose a threat.

In a hospital, Evolv’s presence can alert visitors, patients and staff that the hospital is committed to safety, which is particularly important given the prevalence of violence in healthcare settings. Healthcare workers are five times as likely to suffer a workplace violence injury when compared to other professionals.

Evolv Express has proven its immediate positive impact for Evolv’s healthcare customers. Windsor Regional Hospital in Windsor, Ontario, just across the border from Detroit, reported that Evolv detected more than 2,000 weapons at the emergency department in less than six months. After installing Evolv Express in its lobby last October, The Hospital of the University of Pennsylvania reported that the system prevented more than 300 weapons from entering the facility in its first three months in use.

Virtua Health learned about Evolv from the Philadelphia Phillies, one of a number of professional baseball teams that partner with Evolv for weapons detection at ballpark entrances.

“Actions speak louder than words and partnering with Evolv demonstrates to our staff, patients and community that violence prevention is one of our top priorities because the safety of those inside our hospitals is paramount,” said Gregory Pease, assistant vice president of security and outpatient services for Virtua Health. “As a former police officer, I’ve seen a number of violence mitigation strategies, and I trust Evolv. The results speak for themselves.”

Virtua Health is at the forefront of gun violence prevention in southern New Jersey. The health system co-sponsored a statewide gun buyback initiative a few years ago, and works with the community to support gun safety education. In Evolv’s second annual Gun Violence in America survey, 36% of Americans said they believe they or someone they love are extremely/likely to encounter an active shooter in their lifetime.

“People have enough on their minds when they’re in a hospital, and whether or not they are safe in that environment should not be a concern,” said Jay Muelhoefer, chief commercial officer for Evolv Technology. “Evolv is proud to partner with Virtua Health to elevate safety and allow the focus in that setting to be on improved health outcomes.”

Evolv’s more than 4,500 systems deployed worldwide help secure leading theme parks, performing arts centers, casinos, places of worship, sports venues and schools, in addition to hospitals.

About Evolv Technology

Evolv Technology (NASDAQ: EVLV) is transforming human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to work, learn, and play. Evolv has digitally transformed the gateways in places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than a billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal’s (SBJ) awards for “Best In Fan Experience Technology” and “Best In Sports Technology”. Evolv®, Evolv Express®, Evolv Insights®, Evolv Cortex AI®, and Evolv Visual Gun Detection™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit https://evolvtechnology.com.

Forward-looking Statements

Certain statements in this press release may constitute “forward-looking” statements and information, within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events or our Company’s performance and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the risk factors set forth in our Annual Report on Form 10-K for the year ended on December 31, 2023, that was filed with the SEC on February 29, 2024, as may be updated in other filings we make with the SEC, including our Quarterly Report on Form 10-Q for the quarter ended on March 31, 2024 that was filed with the SEC on May 9, 2024. These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.